Gregory J. Divis serves as Executive at AVADEL PHARMACEUTICALS PLC, where they oversee executive responsibilities. Since joining the company, Gregory J. Divis has executed 4 insider transactions totaling $335.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 10, 2023 involved purchasing 10,000 shares valued at $132.0K.
Gregory J. Divis currently holds 159,100 shares of AVADEL PHARMACEUTICALS PLC (AVDL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory J. Divis has been a net buyer of AVDL stock. They have purchased $335.6K and sold $0 worth of shares.
Gregory J. Divis's most recent insider trade was on Aug 10, 2023, when they purchased 10,000 shares at $13.20 per share.
Get notified when new Form 4 filings are submitted
| $2.05 |
| Discretionary |
| May 18, 2022 | JAGX | $0 | Option Exercise | 12,133 | $N/A | Discretionary |
| Aug 12, 2020 | AVDL | $101.1K | Purchase | 13,000 | $7.78 | Discretionary |